Questions about AstraZeneca jab linger
Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against COVID-19 are more frequent
Read morePersistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against COVID-19 are more frequent
Read moreFrance and Russia prepared to beef up their coronavirus inoculation programmes from next week, even as authorities on Sunday sought
Read more